Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast Cancer. | Ann Surg Oncol | 2023 | 37567976 | PubTator, text mining | PubMed |
| Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts. | Cells | 2023 | 37566074 | PubTator, text mining | PubMed |
| Predicting Duodenal Cancer Risk in Patients with Familial Adenomatous Polyposis Using Machine Learning Model. | Turk J Gastroenterol | 2023 | 37565794 | PubTator, text mining | PubMed |
| Editorial: Neuroendocrine tumors: the road to precision medicine. | Front Endocrinol (Lausanne) | 2023 | 37564989 | PubTator, text mining | PubMed |
| Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. | JAMA Netw Open | 2023 | 37556141 | PubTator, text mining | PubMed |
| miR-34a-FOXP1 Loop in Ovarian Cancer. | ACS Omega | 2023 | 37546627 | PubTator, text mining | PubMed |
| Colorectal cancer and therapy response: a focus on the main mechanisms involved. | Front Oncol | 2023 | 37538108 | PubTator, text mining | PubMed |
| Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes. | J Med Genet | 2023 | 37536918 | PubTator, text mining | PubMed |
| Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. | JCO Precis Oncol | 2023 | 37535880 | PubTator, text mining | PubMed |
| First report of medulloblastoma in a patient with MUTYH-associated polyposis. | Neuropathol Appl Neurobiol | 2023 | 37524406 | PubTator, text mining | PubMed |
| Immunomodulatory actions of vitamin D in various immune-related disorders: a comprehensive review. | Front Immunol | 2023 | 37520529 | PubTator, text mining | PubMed |
| Heterozygous Pathogenic Nonsense Variant in the ATM Gene in a Family with Unusually High Gastric Cancer Susceptibility. | Biomedicines | 2023 | 37509701 | PubTator, text mining | PubMed |
| KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies. | Cancers (Basel) | 2023 | 37509241 | PubTator, text mining | PubMed |
| Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis. | Cancers (Basel) | 2023 | 37509234 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Technology: Current Trends and Advancements. | Biology (Basel) | 2023 | 37508427 | PubTator, text mining | PubMed |
| Antioxidative Role of Heterophagy, Autophagy, and Mitophagy in the Retina and Their Association with the Age-Related Macular Degeneration (AMD) Etiopathogenesis. | Antioxidants (Basel) | 2023 | 37507908 | PubTator, text mining | PubMed |
| Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients. | Eur J Hum Genet | 2023 | 37507557 | PubTator, text mining | PubMed |
| Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. | Front Oncol | 2023 | 37492478 | PubTator, text mining | PubMed |
| Germline whole genome sequencing in adults with multiple primary tumors. | Fam Cancer | 2023 | 37481477 | PubTator, text mining | PubMed |
| Lipoylation is dependent on the ferredoxin FDX1 and dispensable under hypoxia in human cells. | J Biol Chem | 2023 | 37481209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=20